Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off,” offering perspective ahead of the annual J.P. Morgan Healthcare Conference in San Francisco on capital-raising and mergers and acquisitions, in particular for the health care and life sciences sector.
“What a life sciences investor needs is a risk-on environment and a good portfolio of companies that have molecules that can go to market in the near term,” explained Lehot. “And that means they can be an acquisition target.”
(Subscription required)
People
Related News
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.
September 15, 2026
In the News
Scott Ellis Addresses Cost Pressures Driven by Data Center Demand
Foley & Lardner LLP partner Scott Ellis was quoted in Politico’s recent article on the rising costs of building the energy infrastructure needed to support growing data center demand.